NEI
WX

Northwest & Ethical Investments’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Northwest & Ethical Investments’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,675
Closed -$198K – 226
2015
Q2 		$198K Sell
4,675
-5,566
-54% -$235K 0.01% 209
2015
Q1 		$397K Sell
10,241
-1,096
-10% -$42.2K 0.03% 198
2014
Q4 		$382K Buy
11,337
+3,392
+43% +$120K 0.03% 200
2014
Q3 		$278K Buy
7,945
+1,220
+18% +$41.8K 0.02% 204
2014
Q2 		$221K Buy
6,725
+962
+17% +$32.9K 0.01% 217
2014
Q1 		$212K Hold
5,763
– – 0.01% 218
2013
Q4 		$221K Hold
5,763
– – 0.01% 214
2013
Q3 		$158K Buy
+5,763
New +$137K 0.01% 222

Other funds holding WX

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Northwest & Ethical Investments's WX Position: Q3 2015 in Review

Northwest & Ethical Investments sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 4,675 shares — an estimated $198K sold.

Northwest & Ethical Investments first reported a position in WX in Q3 2013 and held it in 8 quarters. The position peaked at $397K in Q1 2015. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

  • Northwest & Ethical Investments reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
  • Northwest & Ethical Investments sold 4,675 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $198K.
  • Northwest & Ethical Investments first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 8 quarters.
  • Northwest & Ethical Investments's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $397K in Q1 2015.
  • 151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on Northwest & Ethical Investments's 13F filing for Q3 2015, filed 8 Jul 2025.